Review of the Molecular Genetics of Basal Cell Carcinoma; Inherited Susceptibility, Somatic Mutations, and Targeted Therapeutics
Basal cell carcinoma (BCC) is a significant public health concern, with more than 3 million cases occurring each year in the United States, and with an increasing incidence. The molecular basis of BCC is complex, involving an interplay of inherited genetic susceptibility, including single nucleotide...
Main Authors: | James M. Kilgour, Justin L. Jia, Kavita Y. Sarin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3870 |
Similar Items
-
Basal cell carcinoma of the lower eyelid affecting the lacrimal canaliculus and reconstruction with transposition flap and oral mucosa graft
by: Manoel Gomes, et al.
Published: (2020-12-01) -
Recommendations for Cost-Conscious Treatment of Basal Cell Carcinoma
by: Palak V. Patel, et al.
Published: (2023-08-01) -
Evaluation of surgical margins according to the histological type of basal cell carcinoma
by: Charles Antonio Pires de Godoy, et al.
Published: (2017-03-01) -
Rapid resolution of recalcitrant basal cell carcinoma of the ear with topical tirbanibulin
by: Angela Moore, MD, et al.
Published: (2022-10-01) -
Genomic bases of non-syndromic basal cell carcinoma:
literature review
by: Daniel Sundfeld Spiga Real
Published: (2021-09-01)